Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Langmuir ; 40(23): 12167-12178, 2024 Jun 11.
Artigo em Inglês | MEDLINE | ID: mdl-38808371

RESUMO

Gold nanoparticles (AuNPs) hold promise in biomedicine, but challenges like aggregation, protein corona formation, and insufficient biocompatibility must be thoroughly addressed before advancing their clinical applications. Designing AuNPs with specific protein corona compositions is challenging, and strategies for corona elimination, such as coating with polyethylene glycol (PEG), have limitations. In this study, we introduce a commercially available zwitterionic derivative of glutathione, glutathione monoethyl ester (GSHzwt), for the surface coating of colloidal AuNPs. Particles coated with GSHzwt were investigated alongside four other AuNPs coated with various ligands, including citrate ions, tiopronin, glutathione, cysteine, and PEG. We then undertook a head-to-head comparison of these AuNPs to assess their behavior in biological fluid. GSHzwt-coated AuNPs exhibited exceptional resistance to aggregation and protein adsorption. The particles could also be readily functionalized with biotin and interact with streptavidin receptors in human plasma. Additionally, they exhibited significant blood compatibility and noncytotoxicity. In conclusion, GSHzwt provides a practical and easy method for the surface passivation of AuNPs, creating "stealth" particles for potential clinical applications.


Assuntos
Glutationa , Ouro , Nanopartículas Metálicas , Propriedades de Superfície , Ouro/química , Nanopartículas Metálicas/química , Glutationa/química , Humanos , Tamanho da Partícula , Adsorção , Materiais Revestidos Biocompatíveis/química , Materiais Revestidos Biocompatíveis/farmacologia
2.
Langmuir, v. 40, n. 23, 12167−12178, mai. 2024
Artigo em Inglês | Sec. Est. Saúde SP, SESSP-IBPROD, Sec. Est. Saúde SP | ID: bud-5431

RESUMO

Gold nanoparticles (AuNPs) hold promise in biomedi-cine, but challenges like aggregation, protein corona formation, andinsufficient biocompatibility must be thoroughly addressed beforeadvancing their clinical applications. Designing AuNPs with specificprotein corona compositions is challenging, and strategies for coronaelimination, such as coating with polyethylene glycol (PEG), havelimitations. In this study, we introduce a commercially availablezwitterionic derivative of glutathione, glutathione monoethyl ester(GSHzwt), for the surface coating of colloidal AuNPs. Particles coatedwith GSHzwt were investigated alongside four other AuNPs coated withvarious ligands, including citrate ions, tiopronin, glutathione, cysteine,and PEG. We then undertook a head-to-head comparison of theseAuNPs to assess their behavior in biological fluid. GSHzwt-coated AuNPsexhibited exceptional resistance to aggregation and protein adsorption. The particles could also be readily functionalized with biotinand interact with streptavidin receptors in human plasma. Additionally, they exhibited significant blood compatibility andnoncytotoxicity. In conclusion, GSHzwt provides a practical and easy method for the surface passivation of AuNPs, creating “stealth”particles for potential clinical applications.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA